Literature DB >> 9635470

Isolated so-called apraxia of eyelid opening: report of 10 cases and a review of the literature.

G Defazio1, P Livrea, P Lamberti, R De Salvia, G Laddomada, M Giorelli, E Ferrari.   

Abstract

So-called apraxia of eyelid opening (scAEO) has been described chiefly in the context of extrapyramidal disorders. We described 10 new patients with scAEO developing in the absence of any other CNS sign and reviewed the 11 cases with isolated scAEO reported in the literature. Combining our patients and those from the literature, peak age at onset was in the 6th decade and there was a female preponderance of 2:1. The characteristic inability to initiate lid elevation was frequently associated with failure to sustain lid elevation, thus suggesting that eyelid motor control may be abnormal in isolated scAEO. Antecedent events included ocular signs and symptoms consistent with diseases of eyes or face (4 cases in our series and 2 in the literature), chronic treatment with flunarizine (1 case), and family history of dystonia (1 case). Flunarizine discontinuation led to sustained remission of the eyelid disturbance. Overall, these clues suggest the involvement of the extrapyramidal system in the pathophysiology of isolated scAEO. Familial clustering of isolated scAEO in one of our patients may be in favor of a genetic contribution. In our series, botulinum toxin administration close to the pretarsal part of the orbicularis oculi muscle significantly improved scAEO in 8/10 cases, whereas orbital/preseptal injection had no effect. We conclude that the term 'apraxia' may not be the correct descriptive term even when the eyelid disturbance occurs without any other CNS disease.

Entities:  

Mesh:

Year:  1998        PMID: 9635470     DOI: 10.1159/000007935

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  9 in total

Review 1.  Awakening Ptosis: A Clinical Review.

Authors:  Abidemi Idowu Otaiku
Journal:  Neuroophthalmology       Date:  2018-06-13

2.  Effects of varying subthalamic nucleus stimulation on apraxia of lid opening in Parkinson's disease.

Authors:  Giorgio Tommasi; Paul Krack; Valérie Fraix; Pierre Pollak
Journal:  J Neurol       Date:  2012-02-17       Impact factor: 4.849

3.  A family study on primary blepharospasm.

Authors:  G Defazio; D Martino; M S Aniello; G Masi; G Abbruzzese; S Lamberti; E M Valente; F Brancati; P Livrea; A Berardelli
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-02       Impact factor: 10.154

4.  Development of a Clinical Rating Scale for the Severity of Apraxia of Eyelid Opening, Either Isolated or Associated with Blepharospasm.

Authors:  Gina Ferrazzano; Antonella Muroni; Antonella Conte; Tommaso Ercoli; Giorgio Tamburini; Giovanni Fabbrini; Alfredo Berardelli; Giovanni Defazio
Journal:  Mov Disord Clin Pract       Date:  2020-09-22

Review 5.  Cranial movement disorders: clinical features, pathophysiology, differential diagnosis and treatment.

Authors:  Giovanni Fabbrini; Giovanni Defazio; Carlo Colosimo; Philip D Thompson; Alfredo Berardelli
Journal:  Nat Clin Pract Neurol       Date:  2009-02

6.  Apraxia of Lid Opening in Subthalamic Nucleus Deep Brain Stimulation for Parkinson's Disease-Frequency, Risk Factors and Response to Treatment.

Authors:  Syam Krishnan; Kuldeep Shetty; Divya Kalikavil Puthanveedu; Krishnakumar Kesavapisharady; Jissa Vinoda Thulaseedharan; Gangadhara Sarma; Asha Kishore
Journal:  Mov Disord Clin Pract       Date:  2021-04-12

7.  Simultaneous loss of bilateral voluntary eyelid opening and sustained winking response following bilateral posterior cerebral artery infarction.

Authors:  Joon Yeop Kim; Yong Wook Kim; Hyoung Seop Kim
Journal:  Ann Rehabil Med       Date:  2015-04-24

8.  Macaque monkey trigeminal blink reflex circuits targeting levator palpebrae superioris motoneurons.

Authors:  Susan Warren; Paul J May
Journal:  J Comp Neurol       Date:  2021-06-11       Impact factor: 3.028

Review 9.  Eyelid Dysfunction in Neurodegenerative, Neurogenetic, and Neurometabolic Disease.

Authors:  Ali G Hamedani; Daniel R Gold
Journal:  Front Neurol       Date:  2017-07-18       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.